Literature DB >> 8843694

Production of interferon-gamma and interleukin-4 by splenocytes in mice infected with Paragonimus westermani.

M H Shin1, D Y Min.   

Abstract

The TH cytokine responses of spleen cells stimulated with Con A from mice infected with Paragonimus westermani were examined. The spleen cell culture supernatants were assayed for TH1-specific IFN-gamma and TH2-specific IL-4. Cytokine responses for IL-4 peaked at three days (410 +/- 60.9 pg/ml), persisted at a high level until the second week (343 +/- 59.0 pg/ml), and then decreased slowly four and six weeks after infection. IFN-gamma production by splenocytes only increased during the first week (151 +/- 32.3 pg/ml) and declined abruptly after the second week of infection. IFN-gamma production by splenocytes of infected mice was not observed during the sixth week of infection. In addition, serum IL-4 and IFN-gamma were measured. Serum IL-4 was not detected in substantial quantity until four to six weeks after infection. The time course of serum IL-4 was not correlated with that of IL-4 production by splenocytes. Serum IFN-gamma was undetectable during the entire course of infection. These results suggest that TH2 cytokine responses, rather than TH1, predominate in mice infected with P. westermani.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843694     DOI: 10.3347/kjp.1996.34.3.185

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  2 in total

1.  Changes of splenocyte IFN-gamma mRNA synthesis in rats infected with Paragonimus westermani.

Authors:  J K Cho; H S Kwon; K H Joo; J S Lee; S W Cho
Journal:  Korean J Parasitol       Date:  1999-12       Impact factor: 1.341

2.  Enhanced Efficacy of Immunization with a Foot-and-Mouth Disease Multi-Epitope Subunit Vaccine Using Mannan-Decorated Inulin Microparticles.

Authors:  So-Yeon Yoon; Sang-Kee Kang; Ho-Bin Lee; Seo-Ho Oh; Whee-Soo Kim; Hui-Shan Li; Jin-Duck Bok; Chong-Su Cho; Yun-Jaie Choi
Journal:  Tissue Eng Regen Med       Date:  2019-12-09       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.